These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 29587436)
21. Pandemic preparedness: toward a universal influenza vaccine. Roose K; Fiers W; Saelens X Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167 [TBL] [Abstract][Full Text] [Related]
22. The Quest for a Truly Universal Influenza Vaccine. Jang YH; Seong BL Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895 [TBL] [Abstract][Full Text] [Related]
23. Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections. Bernasconi V; Bernocchi B; Ye L; Lê MQ; Omokanye A; Carpentier R; Schön K; Saelens X; Staeheli P; Betbeder D; Lycke N Front Immunol; 2018; 9():2060. PubMed ID: 30271406 [TBL] [Abstract][Full Text] [Related]
24. Robust induction of T Lin PH; Liang CY; Yao BY; Chen HW; Pan CF; Wu LL; Lin YH; Hsu YS; Liu YH; Chen PJ; Hu CJ; Yang HC Mol Ther Methods Clin Dev; 2021 Jun; 21():299-314. PubMed ID: 33898629 [TBL] [Abstract][Full Text] [Related]
27. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones. He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655 [TBL] [Abstract][Full Text] [Related]
28. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus. Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941 [TBL] [Abstract][Full Text] [Related]
29. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine. Fox A; Quinn KM; Subbarao K Drugs; 2018 Sep; 78(13):1297-1308. PubMed ID: 30088204 [TBL] [Abstract][Full Text] [Related]
31. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus. Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033 [TBL] [Abstract][Full Text] [Related]
32. Progress on adenovirus-vectored universal influenza vaccines. Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176 [TBL] [Abstract][Full Text] [Related]
33. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
34. An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus. Schwartzman LM; Cathcart AL; Pujanauski LM; Qi L; Kash JC; Taubenberger JK mBio; 2015 Jul; 6(4):e01044. PubMed ID: 26199334 [TBL] [Abstract][Full Text] [Related]
35. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
36. Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells. Cox F; Baart M; Huizingh J; Tolboom J; Dekking L; Goudsmit J; Saeland E; Radošević K PLoS One; 2015; 10(12):e0145243. PubMed ID: 26696245 [TBL] [Abstract][Full Text] [Related]
37. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus. Di Mario G; Soprana E; Gubinelli F; Panigada M; Facchini M; Fabiani C; Garulli B; Basileo M; Cassone A; Siccardi A; Donatelli I; Castrucci MR Pathog Glob Health; 2017 Mar; 111(2):69-75. PubMed ID: 28081672 [TBL] [Abstract][Full Text] [Related]
39. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118 [TBL] [Abstract][Full Text] [Related]
40. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L; Kays SK; Zimmer G; von Messling V J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]